Genmab A/S buy tbackenh
Start price
22.05.14
/
50%
€26.87
Target price
29.05.14
€33.00
Performance (%)
6.96%
End price
29.05.14
€28.74
Summary
This prediction ended on 29.05.14 with a price of €28.74. The BUY prediction by tbackenh finished with a performance of 6.96%. tbackenh has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Genmab A/S | 3.137% | 3.137% | 40.127% | -21.772% |
| iShares Core DAX® | -1.764% | 2.259% | 15.213% | 61.619% |
| iShares Nasdaq 100 | -1.632% | -0.193% | 3.293% | 100.420% |
| iShares Nikkei 225® | -2.451% | 4.086% | 17.198% | 50.705% |
| iShares S&P 500 | -2.252% | -0.151% | 0.574% | 63.730% |
Comments by tbackenh for this prediction
In the thread Genmab A/S diskutieren
Genmab AS
Dänischer Biotechnologiewert, der mit "interessanten" Zahlen eine Beimischung in dem etwas volalileren Umfeld der Biotechnologietitel sein könnte. Ich bin hier positiv, weil noch keine Übertreibung auszumachen ist.
(Stop Loss Kurs erreicht)